Immune cell puzzle COVID-19: how do SARS-CoV infections contribute to psychiatric diseases? Matthias JungDan Rujescu Editorial Open access 04 August 2020 Pages: 643 - 644
When does shared decision making is adopted in psychiatric clinical practice? Results from a European multicentric study M. LucianoG. SampognaFor the CEDAR Study Group Original Paper 07 June 2019 Pages: 645 - 653
Mean age and gender distribution of patients with major mental disorders participating in clinical trials Borwin BandelowKatharina Schüller Original Paper 02 January 2019 Pages: 655 - 659
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a “real-world” 2-year follow-up trial Rebecca SchennachMichael RiedelHans-Jürgen Möller Original Paper 28 August 2019 Pages: 661 - 671
Psychiatric symptoms and quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study Nicolas HoertelLéa RotenbergCSA Study Group Original Paper 27 May 2019 Pages: 673 - 688
Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 15-year follow-up study M. AlbusW. HubmannH. Küchenhoff Original Paper 18 June 2019 Pages: 689 - 698
A 2-year longitudinal study of neuropsychological functioning, psychosocial adjustment and rehospitalisation in schizophrenia and major depression Schaub AnnetteGoerigk StephanFalkai Peter Original Paper Open access 03 April 2020 Pages: 699 - 708
Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study Siv Hege LyngstadErlend Strand GardsjordAnn Færden Original Paper Open access 04 March 2020 Pages: 709 - 722
Could the severity of symptoms of schizophrenia affect ability of self-appraisal of cognitive deficits in patients with schizophrenia? Lack of insight as a mediator between the two domains Valeria SantarelliCarmela MarucciRodolfo Rossi Original Paper 13 November 2019 Pages: 723 - 728
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial Elena Huerta-RamosJavier LabadJudith Usall Original Paper 14 November 2019 Pages: 729 - 737
Neuropsychological, clinical and environmental predictors of severe mental disorders in offspring of patients with schizophrenia Teresa Sánchez-GutiérrezElisa Rodríguez-ToscanoDolores Moreno Original Paper 16 July 2019 Pages: 739 - 748
Do sleep disturbances contribute to cognitive impairments in schizophrenia spectrum and bipolar disorders? Jannicke Fjæra LaskemoenCamilla BüchmannCarmen Simonsen Original Paper 05 October 2019 Pages: 749 - 759
Facial emotion recognition in people with schizophrenia and a history of violence: a mediation analysis Viola BulgariMattia BavaGiuseppe Carrà Original Paper 20 May 2019 Pages: 761 - 769
Hippocampal subfield and amygdala nuclei volumes in schizophrenia patients with a history of violence Natalia TesliDennis van der MeerUnn K. Haukvik Original Paper Open access 24 January 2020 Pages: 771 - 782
Mental health treatment online during the COVID-19 outbreak Nannan HuShengming PanHongjing Mao Letter to the Editor 02 May 2020 Pages: 783 - 784
The COVID-19 pandemic brings a second wave of social isolation and disrupted services Alberto StefanaEric A. YoungstromAntonios Dakanalis Letter to the Editor 15 May 2020 Pages: 785 - 786
Correction to: Migration and schizophrenia: meta-analysis and explanatory framework Jonathan HensslerLasse BrandtAndreas Heinz Correction 12 May 2020 Pages: 787 - 787
